🧫
Ferroptosis inducer erastin counteraction experiment
active
experiment
Created: 2026-04-10T22:49:03
By: etl-v1-backfill
Quality:
50%
✓ SciDEX
ID: exp-d63ccab7-78e8-49d0-8cb3-4b08c203f969
🧫 Experiment Protocol
Exploratorysepsis-associated acute lung injuryRAW264.7 cells and/or mouse modelproposed
This mechanistic validation experiment used erastin, a known ferroptosis inducer, to test whether the protective effects of acteoside could be reversed by promoting ferroptosis. The experiment was designed to confirm that acteoside's beneficial effects in SALI are specifically mediated through ferroptosis inhibition. Researchers likely treated cells or animals with acteoside along with erastin to demonstrate that inducing ferroptosis would counteract acteoside's protective benefits. This approach provided crucial evidence that ferroptosis is indeed the primary pathway through which acteoside exerts its protective effects against sepsis-associated lung injury.
PRIMARY OUTCOME
reversal of acteoside's protective effects
EXPECTED OUTCOMES
erastin counteracts acteoside's benefits
SUCCESS CRITERIA
loss of acteoside's protective effects when ferroptosis is induced
PROTOCOL
co-treatment with acteoside and erastin, assessment of protective effects
Source: PMID 41895086 ↗
🧫 Experiment Extras
PATHWAY
ferroptosis pathway
MARKET PRICE
$0.50
STATUS
proposed
▸Metadataorigin_type: v1_polymorphic_backfill
| origin_type | v1_polymorphic_backfill |
| source_table | experiments |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.